Selected References: Aslinia F, et al. 2006. Megaloblastic anemia and other causes of macrocytosis. Clinical Medicine & Research 4.3:236-41. Benjamin RH, et al. 2025. National Birth Defects Prevention Study and the Birth Defects Study to Evaluate Pregnancy Exposures. Maternal folic acid supplement use, folate intake, and preterm birth among infants with spina bifida. Birth Defects Res. 117(12):e70008. Bortolus R., et al. 2021. Efficacy of 4.0 mg versus 0.4 mg folic acid …
El Blog del Bebé
Acerca de Nuestro Baby Blog
Cada persona quiere saber qué es lo mejor para su bebé, especialmente cuando se trata de saber cómo minimizar los riesgos de exposición. Nuestras historias cercanas están repletas de información práctica de nuestro personal rotativo de blogueros expertos de MotherToBaby. Cualquiera que sea el tema que esté buscando, nuestros blogs le proporcionarán una gran base para obtener más información.
Depot Medroxyprogesterone Acetate (Depo Provera®)
Selected References: Baheiraei A, et al. 2001. Effects of progestogen-only contraceptives on breast-feeding and infant growth Int J Gynaecol Obstet, 74; 203–205. Borgatta L, et al. 2002. Pregnancies diagnosed during Depo- Provera use. Contraception. Sep;66(3):169-72. Callahan R et al. 2015. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: A systemic review. Contraception 92(6):514-522. Dahlberg K. 1982. Some effects …
OnabotulinumtoxinA (Botox®)
Selected References: Bodkin CL, et al. 2005. OnabotulinumtoxinA therapy during pregnancy. Mov Disord 20(8): 1081-1082. Briggs J, et al. 2005. Drugs in pregnancy and lactation, 7th Ed. 174-175. Lippincott Williams & Wilkins: Philadelphia. Brin MF, et al. 2016. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiology and Drug Safety. 25: 179–187. Brin, MF, et al 2023. Pregnancy outcomes in patients exposed to onabotulinumtoxinA treatment. Neurology. …
Metoprolol
Selected References: Alembic Pharmaceuticals Inc. 2017. Metoprolol tartrate product labeling. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24837d82-0f3f-4482-9af0-31e5f675c30f. Accessed 27 Jan 2026. Bateman BT, et al. 2016. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics; 138(3). pii:e20160731. Battarbee AN, et al. 2020. Chronic hypertension in pregnancy. Am J Obstet Gynecol; 222(6):532-541. Davis RL, et al. 2011. …
Propranolol
Selected References: Bateman BT, et al. 2016. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics 138(3) pii:e20160731. Bauer et al. 1979. Propranolol in human plasma and breast milk. Am J Cardiol 43(4):860-862. Bratton S, et al. 2024. Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis. Journal of Perinatal Medicine. 52.8: 858-862. Davis RL, et al. 2011. Risks of congenital malformations and …
